Cargando…
Antiviral Compounds from Myxobacteria
Viral infections including human immunodeficiency virus (HIV), cytomegalovirus (CMV), hepatitis B virus (HBV), and hepatitis C virus (HCV) pose an ongoing threat to human health due to the lack of effective therapeutic agents. The re-emergence of old viral diseases such as the recent Ebola outbreaks...
Autores principales: | Mulwa, Lucky S., Stadler, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163824/ https://www.ncbi.nlm.nih.gov/pubmed/30029487 http://dx.doi.org/10.3390/microorganisms6030073 |
Ejemplares similares
-
Lanyamycin, a macrolide antibiotic from Sorangium cellulosum, strain Soce 481 (Myxobacteria)
por: Mulwa, Lucky S, et al.
Publicado: (2018) -
Myxobacteria as a Source of New Bioactive Compounds: A Perspective Study
por: Bhat, Mudasir Ahmad, et al.
Publicado: (2021) -
Are Myxobacteria intelligent?
por: Kaiser, Dale
Publicado: (2013) -
Metabolic and Biosynthetic Diversity in Marine Myxobacteria
por: Gemperlein, Katja, et al.
Publicado: (2018) -
Myxobacteria: Physiology and Regulation
por: Whitworth, David E.
Publicado: (2022)